Hypertermic limb perfusion in lymphangiosarcoma Upcoming changes to history Translation history will soon only be available when you are signed in and will be centrally managed within My Activity. Past history will be cleared during this upgrade, so make sure to save translations you want to remember for ease of access later. Got it Hypertermická perfuze končetiny u lymfangiosarkomu 50/5000 Hypertermic limb perfusion in lymphangiosarcoma
Abstract
Hypertermic limb perfusion in lymphangiosarcoma Indications of hyperthermic limb perfusion (HILP) include unresectable limb soft tissue sarcoma, selected cases of malignant limb melanoma with multiple in-transit metastases, no distant metastases, and other, uncommon soft limb tumors, according to current Blue Book recommendations (7). We also include lymphangiosarcoma (sy Stewart-Tréves).
In our patient it was a woman of advanced age with the development of sarcoma at a distance of 21 years from the primary diagnosis of breast cancer and 15 years from the manifestations of lymphedema. The patient met the indication of locally advanced, unresectable sarcoma.
In addition to the biopsy, other sections of the so-called premalignant angiomatosis were apparent on the limb. The effect of the treatment was excellent, with a duration of complete regression of 12 months while maintaining full limb functionality.
It can be assumed that a new HILP could again have a therapeutic effect, but the patient does not want to repeat the procedure.